- Home
- IOVA vs BKU Comparison
IOVA vs BKU Comparison
Compare IOVA & BKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- BKU
- Stock Information
- Founded
- IOVA 2007
- BKU 2009
- Country
- IOVA United States
- BKU United States
- Employees
- IOVA N/A
- BKU N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- BKU Savings Institutions
- Sector
- IOVA Health Care
- BKU Finance
- Exchange
- IOVA Nasdaq
- BKU Nasdaq
- Market Cap
- IOVA 975.1M
- BKU 2.8B
- IPO Year
- IOVA N/A
- BKU 2011
- Fundamental
- Price
- IOVA $2.27
- BKU $39.32
- Analyst Decision
- IOVA Buy
- BKU Hold
- Analyst Count
- IOVA 11
- BKU 11
- Target Price
- IOVA $11.90
- BKU $41.82
- AVG Volume (30 Days)
- IOVA 11.1M
- BKU 594.2K
- Earning Date
- IOVA 11-06-2025
- BKU 10-21-2025
- Dividend Yield
- IOVA N/A
- BKU 3.15%
- EPS Growth
- IOVA N/A
- BKU 51.05
- EPS
- IOVA N/A
- BKU 3.41
- Revenue
- IOVA $241,525,000.00
- BKU $999,760,000.00
- Revenue This Year
- IOVA $67.40
- BKU $15.20
- Revenue Next Year
- IOVA $56.32
- BKU $6.43
- P/E Ratio
- IOVA N/A
- BKU $11.54
- Revenue Growth
- IOVA 636.99
- BKU 13.39
- 52 Week Low
- IOVA $1.64
- BKU $28.21
- 52 Week High
- IOVA $12.51
- BKU $44.45
- Technical
- Relative Strength Index (RSI)
- IOVA 45.40
- BKU 60.27
- Support Level
- IOVA $2.27
- BKU $38.44
- Resistance Level
- IOVA $2.46
- BKU $39.86
- Average True Range (ATR)
- IOVA 0.15
- BKU 0.78
- MACD
- IOVA -0.00
- BKU -0.01
- Stochastic Oscillator
- IOVA 29.09
- BKU 67.47
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.